Molecules and Cells

Korean Society for Molecular and Cellular Biology (한국분자세포생물학회)
권호 표지
DOI QR코드

DOI QR Code

NDRG2 Controls COX-2/PGE2-Mediated Breast Cancer Cell Migration and Invasion

  • Kim, Myung-Jin (Department of Biological Science and the Research Center for Women's Disease, Sookmyung Women's University) ;
  • Kim, Hak-Su (Department of Biological Science and the Research Center for Women's Disease, Sookmyung Women's University) ;
  • Lee, Soo-Hwan (Department of Physiology, Ajou University School of Medicine) ;
  • Yang, Young (Department of Biological Science and the Research Center for Women's Disease, Sookmyung Women's University) ;
  • Lee, Myeong-Sok (Department of Biological Science and the Research Center for Women's Disease, Sookmyung Women's University) ;
  • Lim, Jong-Seok (Department of Biological Science and the Research Center for Women's Disease, Sookmyung Women's University)
  • Received : 2014.08.19
  • Accepted : 2014.09.02
  • Published : 2014.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

N-myc downstream-regulated gene 2 (NDRG2), which is known to have tumor suppressor functions, is frequently down-regulated in breast cancers and potentially involved in preventing the migration and invasion of malignant tumor cells. In the present study, we examined the inhibitory effects of NDRG2 overexpression, specifically focusing on the role of cyclooxygenase-2 (COX-2) in the migration of breast cancer cells. NDRG2 overexpression in MDA-MB-231 cells inhibited the expression of the COX-2 mRNA and protein, the transcriptional activity of COX-2, and prostaglandin $E_2$ ($PGE_2$) production, which were induced by a treatment with phorbol-12-myristate-13-acetate (PMA). Nuclear transcription factor-${\kappa}B$ (NF-${\kappa}B$) signaling attenuated by NDRG2 expression resulted in a decrease in PMA-induced COX-2 expression. Interestingly, the inhibition of COX-2 strongly suppressed PMA-stimulated migration and invasion in MDA-MB-231-NDRG2 cells. Moreover, siRNA-mediated knockdown of NDRG2 in MCF7 cells increased the COX-2 mRNA and protein expression levels and the PMA-induced COX-2 expression levels. Consistent with these results, the migration and invasion of MCF7 cells treated with NDRG2 siRNA were significantly enhanced following treatment with PMA. Taken together, our data show that the inhibition of NF-${\kappa}B$ signaling by NDRG2 expression is able to suppress cell migration and invasion through the down-regulation of COX-2 expression.

Keywords

References

  1. Chen, C.C., Hsieh, T.F., Chang, C.H., Ma, W.L., Hung, X.F., Tsai, Y.R., Lin, M.H., Zhang, C., Chang, C., and Shyr, C.R. (2013). Androgen receptor promotes the migration and invasion of upper urinary tract urothelial carcinoma cells through the upregulation of MMP-9 and COX-2. Oncol. Rep. 30, 979-985. https://doi.org/10.3892/or.2013.2506
  2. Deng, Y., Yao, L., Chau, L., Ng, S.S., Peng, Y., Liu, X., Au, W.S., Wang, J., Li, F., Ji, S., et al. (2003). N-Myc downstream-regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation. Int. J. Cancer 106, 342-347. https://doi.org/10.1002/ijc.11228
  3. Flowers, M., and Thompson, P.A. (2009). t10c12 conjugated linoleic acid suppresses HER2 protein and enhances apoptosis in SKBr3 breast cancer cells: possible role of COX2. PLoS One 4, e5342. https://doi.org/10.1371/journal.pone.0005342
  4. Fosslien, E. (2000). Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia. Crit. Rev. Clin. Lab. Sci. 37, 431-502. https://doi.org/10.1080/10408360091174286
  5. Funakoshi-Tago, M., Shimizu, T., Tago, K., Nakamura, M., Itoh, H., Sonoda, Y., and Kasahara, T. (2008). Celecoxib potently inhibits TNFalpha-induced nuclear translocation and activation of NFkappaB. Biochem. Pharmacol. 76, 662-671. https://doi.org/10.1016/j.bcp.2008.06.015
  6. Greenhough, A., Smartt, H.J., Moore, A.E., Roberts, H.R., Williams, A.C., Paraskeva, C., and Kaidi, A. (2009). The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis 30, 377-386. https://doi.org/10.1093/carcin/bgp014
  7. Hao, Q., Zhang, C., Gao, Y., Wang, S., Li, J., Li, M., Xue, X., Li, W., Zhang, W., and Zhang, Y. (2014). FOXP3 inhibits NF-kappaB activity and hence COX2 expression in gastric cancer cells. Cell. Signal. 26, 564-569. https://doi.org/10.1016/j.cellsig.2013.11.030
  8. Ho, M.Y., Liang, S.M., Hung, S.W., and Liang, C.M. (2013). MIG-7 controls COX-2/PGE2-mediated lung cancer metastasis. Cancer Res. 73, 439-449. https://doi.org/10.1158/0008-5472.CAN-12-2220
  9. Imada, T., Matsuoka, J., Nobuhisa, T., Okawa, T., Murata, T., Tabuchi, Y., Shirakawa, Y., Ohara, N., Gunduz, M., Nagatsuka, H., et al. (2006). COX-2 induction by heparanase in the progression of breast cancer. Int. J. Mol. Med. 17, 221-228.
  10. Lee, D.C., Kang, Y.K., Kim, W.H., Jang, Y.J., Kim, D.J., Park, I.Y., Sohn, B.H., Sohn, H.A., Lee, H.G., Lim, J.S., et al. (2008). Functional and clinical evidence for NDRG2 as a candidate suppressor of liver cancer metastasis. Cancer Res. 68, 4210-4220. https://doi.org/10.1158/0008-5472.CAN-07-5040
  11. Lerebours, F., Vacher, S., Andrieu, C., Espie, M., Marty, M., Lidereau, R., and Bieche, I. (2008). NF-kappa B genes have a major role in inflammatory breast cancer. BMC Cancer 8, 41. https://doi.org/10.1186/1471-2407-8-41
  12. Li, W., Mao, Z., Fan, X., Cui, L., and Wang, X. (2013). Cyclooxygenase 2 promoted the tumorigenecity of pancreatic cancer cells. Tumour Biol. 35, 2271-2278.
  13. Lorentzen, A., Lewinsky, R.H., Bornholdt, J., Vogel, L.K., and Mitchelmore, C. (2011). Expression profile of the N-myc downstream regulated gene 2 (NDRG2) in human cancers with focus on breast cancer. BMC Cancer 11, 14. https://doi.org/10.1186/1471-2407-11-14
  14. Ma, J., Liu, W., Yan, X., Wang, Q., Zhao, Q., Xue, Y., Ren, H., Wu, L., Cheng, Y., Li, S., et al. (2012). Inhibition of endothelial cell proliferation and tumor angiogenesis by up-regulating NDRG2 expression in breast cancer cells. PLoS One 7, e32368. https://doi.org/10.1371/journal.pone.0032368
  15. Melotte, V., Qu, X., Ongenaert, M., van Criekinge, W., de Bruine, A.P., Baldwin, H.S., and van Engeland, M. (2010). The N-myc downstream regulated gene (NDRG) family: diverse functions, multiple applications. FASEB J. 24, 4153-4166. https://doi.org/10.1096/fj.09-151464
  16. Oh, S.S., Kim, D., Kim, D.H., Chang, H.H., Sohn, K.C., Kim, K.H., Jung, S.H., Lee, B.K., Kim, J.H., and Kim, K.D. (2012). NDRG2 correlated with favorable recurrence-free survival inhibits metastasis of mouse breast cancer cells via attenuation of active TGF-beta production. Carcinogenesis 33, 1882-1888. https://doi.org/10.1093/carcin/bgs211
  17. Qu, X., Zhai, Y., Wei, H., Zhang, C., Xing, G., Yu, Y., and He, F. (2002). Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family. Mol. Cell. Biochem. 229, 35-44. https://doi.org/10.1023/A:1017934810825
  18. Shen, L., Qu, X., Ma, Y., Zheng, J., Chu, D., Liu, B., Li, X., Wang, M., Xu, C., Liu, N., et al. (2014). Tumor suppressor NDRG2 tips the balance of oncogenic TGF-beta via EMT inhibition in colorectal cancer. Oncogenesis 3, e86. https://doi.org/10.1038/oncsis.2013.48
  19. Shon, S.K., Kim, A., Kim, J.Y., Kim, K.I., Yang, Y., and Lim, J.S. (2009). Bone morphogenetic protein-4 induced by NDRG2 expression inhibits MMP-9 activity in breast cancer cells. Biochem. Biophys. Res. Commun. 385, 198-203. https://doi.org/10.1016/j.bbrc.2009.05.038
  20. Singh, B., Berry, J.A., Shoher, A., Ayers, G.D., Wei, C., and Lucci, A. (2007). COX-2 involvement in breast cancer metastasis to bone. Oncogene 26, 3789-3796. https://doi.org/10.1038/sj.onc.1210154
  21. Stasinopoulos, I., O'Brien, D.R., Wildes, F., Glunde, K., and Bhujwalla, Z.M. (2007). Silencing of cyclooxygenase-2 inhibits metastasis and delays tumor onset of poorly differentiated metastatic breast cancer cells. Mol. Cancer Res. 5, 435-442. https://doi.org/10.1158/1541-7786.MCR-07-0010
  22. Takai, E., Tsukimoto, M., and Kojima, S. (2013). TGF-beta1 downregulates COX-2 expression leading to decrease of PGE2 production in human lung cancer A549 cells, which is involved in fibrotic response to TGF-beta1. PLoS One 8, e76346. https://doi.org/10.1371/journal.pone.0076346
  23. Williams, C.S., Mann, M., and DuBois, R.N. (1999). The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 18, 7908-7916.
  24. Wu, M.H., Chen, L.M., Hsu, H.H., Lin, J.A., Lin, Y.M., Tsai, F.J., Tsai, C.H., Huang, C.Y., and Tang, C.H. (2013). Endothelin-1 enhances cell migration through COX-2 up-regulation in human chondrosarcoma. Biochim. Biophys. Acta 1830, 3355-3364. https://doi.org/10.1016/j.bbagen.2013.03.014
  25. Yang, Z., Li, C., Wang, X., Zhai, C., Yi, Z., Wang, L., Liu, B., Du, B., Wu, H., Guo, X., et al. (2010). Dauricine induces apoptosis, inhibits proliferation and invasion through inhibiting NF-kappaB signaling pathway in colon cancer cells. J. Cell Physiol. 225, 266-275. https://doi.org/10.1002/jcp.22261
  26. Yao, L., Zhang, J., and Liu, X. (2008). NDRG2: a Myc-repressed gene involved in cancer and cell stress. Acta Biochim. Biophys. Sin. 40, 625-635. https://doi.org/10.1111/j.1745-7270.2008.00434.x

Cited by

  1. A 22q11.2 amplification in the region encoding microRNA-650 correlates with the epithelial to mesenchymal transition in breast cancer primary cultures of Mexican patients vol.50, pp.2, 2017, https://doi.org/10.3892/ijo.2017.3842
  2. NDRG2 Expression Decreases Tumor-Induced Osteoclast Differentiation by Down-regulating ICAM1 in Breast Cancer Cells vol.24, pp.1, 2016, https://doi.org/10.4062/biomolther.2015.105
  3. Doxycycline inhibits the cancer stem cell phenotype and epithelial-to-mesenchymal transition in breast cancer vol.16, pp.8, 2017, https://doi.org/10.1080/15384101.2016.1241929
  4. Macrophages induce EMT to promote invasion of lung cancer cells through the IL-6-mediated COX-2/PGE 2 /β-catenin signalling pathway vol.90, 2017, https://doi.org/10.1016/j.molimm.2017.06.018
  5. Rhus coriaria suppresses angiogenesis, metastasis and tumor growth of breast cancer through inhibition of STAT3, NFκB and nitric oxide pathways vol.6, pp.1, 2016, https://doi.org/10.1038/srep21144
  6. Role of cyclooxygenase-2 in Trypanosoma cruzisurvival in the early stages of parasite host-cell interaction vol.110, pp.2, 2015, https://doi.org/10.1590/0074-02760140311
  7. Loss of NDRG2 enhanced activation of the NF-κB pathway by PTEN and NIK phosphorylation for ATL and other cancer development vol.5, pp.1, 2015, https://doi.org/10.1038/srep12841
  8. Abundant NDRG2 Expression Is Associated with Aggressiveness and Unfavorable Patients’ Outcome in Basal-Like Breast Cancer vol.11, pp.7, 2016, https://doi.org/10.1371/journal.pone.0159073
  9. Cyclooxygenase-2 in tumor-associated macrophages promotes metastatic potential of breast cancer cells through Akt pathway vol.12, pp.12, 2016, https://doi.org/10.7150/ijbs.15943
  10. Loss of NDRG2 Expression Confers Oral Squamous Cell Carcinoma with Enhanced Metastatic Potential vol.77, pp.9, 2014, https://doi.org/10.1158/0008-5472.can-16-2114
  11. Effects of NDRG2 Overexpression on Metastatic Behaviors of HCT116 Colorectal Cancer Cell Line vol.7, pp.4, 2014, https://doi.org/10.15171/apb.2017.080
  12. Cordycepin inhibits lipopolysaccharide-induced cell migration and invasion in human colorectal carcinoma HCT-116 cells through down-regulation of prostaglandin E2 receptor EP4 vol.51, pp.10, 2014, https://doi.org/10.5483/bmbrep.2018.51.10.120
  13. Association of HIF-1α and NDRG2 expression with EMT in gastric cancer tissues vol.14, pp.1, 2019, https://doi.org/10.1515/biol-2019-0025
  14. Association of HIF-1α and NDRG2 expression with EMT in gastric cancer tissues vol.14, pp.1, 2019, https://doi.org/10.1515/biol-2019-0025
  15. The molecular mechanisms of celecoxib in tumor development vol.99, pp.40, 2020, https://doi.org/10.1097/md.0000000000022544
  16. Enhancing Anti-Tumor Activity of Sorafenib Mesoporous Silica Nanomatrix in Metastatic Breast Tumor and Hepatocellular Carcinoma via the Co-Administration with Flufenamic Acid vol.15, pp.None, 2014, https://doi.org/10.2147/ijn.s240436
  17. The Role of Noncoding RNAs in the Regulation of Anoikis and Anchorage-Independent Growth in Cancer vol.22, pp.2, 2014, https://doi.org/10.3390/ijms22020627
  18. Extracellular ATP Mediates Cancer Cell Migration and Invasion Through Increased Expression of Cyclooxygenase 2 vol.11, pp.None, 2014, https://doi.org/10.3389/fphar.2020.617211
  19. CD147 receptor is essential for TFF3-mediated signaling regulating colorectal cancer progression vol.6, pp.1, 2014, https://doi.org/10.1038/s41392-021-00677-2
  20. NDRG2 Expression in Breast Cancer Cells Downregulates PD-L1 Expression and Restores T Cell Proliferation in Tumor-Coculture vol.13, pp.23, 2014, https://doi.org/10.3390/cancers13236112